Drug General Information
Drug ID
D0A8GM
Former ID
DNCL003469
Drug Name
Ublituximab
Synonyms
TG-1101
Drug Type
Antibody
Indication Chronic lymphocytic leukaemia [ICD10:C91] Phase 2 [549929]
Company
TG Therapeutics
Target and Pathway
Target(s) B-lymphocyte antigen CD20 Target Info [533097]
KEGG Pathway Hematopoietic cell lineage
References
Ref 549929Clinical pipeline report, company report or official report of TG THERAPEUTICS.
Ref 533097The optimized anti-CD20 monoclonal antibody ublituximab bypasses natural killer phenotypic features in Waldenstr?m macroglobulinemia. Haematologica. 2015 Apr;100(4):e147-51.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.